Pramod Nagaraja

  • Citations Per Year
Learn More
BACKGROUND Delayed graft function (DGF) and acute rejection (AR) exert an adverse impact on graft outcomes after kidney transplantation using organs from donation after brain-stem death (DBD) donors. Here, we examine the impact of DGF and AR on graft survival in kidney transplants using organs from donation after cardiac death (DCD) donors. METHODS We(More)
New-onset diabetes mellitus (NODAT) is a serious complication following renal transplantation. In this cohort study, we studied 118 nondiabetic renal transplant recipients to examine whether indices of insulin resistance and secretion calculated before transplantation and at 3 months post-transplantation are associated with the development of NODAT within 1(More)
A 56-year-old Caucasian woman presented to a peripheral hospital with 8 months history of abdominal discomfort, nausea, night sweats and lethargy. She had lost 10 kg weight and had recovered from an episode of painless bilateral cheek swelling 2 months prior to presentation. There was no history of rash, red eyes, dry mouth, joint pains, cough,(More)
A 43-year-old previously healthy man presented with a 10-day history of feeling unwell, nausea, vomiting, diarrhoea, myalgia and fever. He had not passed urine for 2 days. He was not taking any medications and denied taking recreational or ‘over the counter’ drugs. On examination, he was dehydrated. Blood pressure was 150/90mmHg. Systemic examination was(More)
INTRODUCTION To expand the donor pool, kidney transplants are being performed using donors who were previously considered unacceptable. We applied the United Network for Organ Sharing criteria to define expanded criteria donors (ECD) within the donation after cardiac death (DCD) and donation after brain stem death (DBD) cohorts. We compared outcomes of DCD(More)
BACKGROUND Metabolic syndrome (MS) diagnosed early after kidney transplantation is a risk factor for developing new-onset diabetes. The aim of this study was to examine whether glucose intolerance and MS identified late after transplantation influence the progression of glycemic abnormalities in kidney transplant recipients. METHODS This is a(More)
  • 1